par Sternon, Jacques 
Référence Revue médicale de Bruxelles, 18, 4, page (286-292)
Publication Publié, 1997
Référence Revue médicale de Bruxelles, 18, 4, page (286-292)
Publication Publié, 1997
Article révisé par les pairs
| Résumé : | Post myocardial infarction preventive strategies are effective in reducing morbidity and mortality. Life threatening risk factors can be controlled by medication in addition to dietary measures. The following update will be proposed on: - new lipidic and non lipidic risk factors; - necessity to control risk factors, nicotine dependence and lipid metabolism disorders in particular; - patient follow-up; -drug treatment efficacy (β- blockers, aspirin, ACEI, statins); - compliance to a varied drag treatment regimen. Three newly developed treatments will be presented: the first sartan, clopidogrel and troglitazone. |
